Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis

Sanjay Popat, Anders Mellemgaard, Kyle Fahrbach, Alison Martin, Maria Rizzo, Rolf Kaiser, Ingolf Griebsch, Martin Reck